Pancreatic Cancer Research

ResearcherFriedrich-Alexander-Universität Erlangen-NürnbergNo recent work listed

Werner Hohenberger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3872-6416; OpenAlex author ID A5102884972, A5108109145. Sources: ClinicalTrials.gov.

Their work

Papers
5 (first author 0, last author 1)
Trials
1
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2003: 1 trial · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 5

  1. R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-… Co-author DOI 10.1007/s00066-020-01680-2↗
  2. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial. Co-author DOI 10.1186/s12885-019-6148-5↗
  3. Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospe… Last author DOI 10.1007/s00066-014-0737-7↗
  4. [S3-guideline exocrine pancreatic cancer]. Co-author DOI 10.1055/s-0033-1356220↗
  5. Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV). Co-author DOI 10.1159/000331239↗

Trials 1

  1. Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By… Study chair NCT00335543↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Henriette Golcher · 3 shared papers, 2015–2021 · strength 0.22
  2. Michael B. Ghadimi · 2 shared papers, 2019–2021 · strength 0.18
  3. Dorota Łubgan · 2 shared papers, 2019–2021 · strength 0.18
  4. Waldemar H. Uhl · 2 shared papers, 2019–2021 · strength 0.18
  5. Robert Grützmann · 2 shared papers, 2019–2021 · strength 0.18
  6. Anke Reinacher‐Schick · 2 shared papers, 2019–2021 · strength 0.18
  7. Helmut Oettle · 2 shared papers, 2019–2021 · strength 0.18
  8. Uwe A. Wittel · 2 shared papers, 2019–2021 · strength 0.18
  9. Sabine Semrau · 1 shared paper, 2021 · strength 0.10
  10. Rainer Fietkau · 1 shared paper, 2021 · strength 0.10
  11. Stefan Hubert Boeck · 1 shared paper, 2021 · strength 0.10
  12. Orlin Belyaev · 1 shared paper, 2019 · strength 0.08
  13. Thomas Baptist Brunner · 1 shared paper, 2015 · strength 0.04
  14. Christiane J. Bruns · 1 shared paper, 2015 · strength 0.04
  15. Sandra Roehrig · 1 shared paper, 2011 · strength 0.02
  16. Frank Boxberger · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.